Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc LNDZF


Primary Symbol: V.EVMT

Healthcare Medical Devices
Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Evome Medical Technologies Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(318)
•••
Post by ANALOG GUYon Apr 05, 2024 5:10pm
251 Views
Post# 35973925

The Future looks very Friendly boys!

The Future looks very Friendly boys!

Evome Medical Technologies has a 360% upside, Leede says

A new development at Evome Medical Technologies (Evome Medical Technologies Stock Quote, Chart, News, Analysts, Financials TSXV:EVMT) has Leede Jones Gable analyst Greg McLeish maintaining his bullish stance on the stock.
In a research update to clients April 4, McLeish maintained his “Buy” rating and price target of $1.15 on EVMT, implying a return of 360% at the time of publication.

The analyst thinks Evome will post EBITDA of $852,000 on revenue of $62.6-million in fiscal 2023. He expects those numbers will be EBITDA of $2.01-million on a topline of $62.2-million in fiscal 2024

 



 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities